Rossella Miccio
Overview
Explore the profile of Rossella Miccio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Portella G, Chatenoud L, Gatti S, Salvati A, Asta L, Lentini S, et al.
J Am Coll Cardiol
. 2024 Dec;
85(1):88-92.
PMID: 39665704
No abstract available.
2.
Lamberti-Castronuovo A, Valente M, Bocchini F, Trentin M, Paschetto M, Bahdori G, et al.
Confl Health
. 2024 Apr;
18(1):36.
PMID: 38658962
Background: Following the change of government in August 2021, the social and economic landscape of Afghanistan deteriorated into an economic and humanitarian crisis. Afghans continue to struggle to access basic...
3.
Valente M, Lamberti-Castronuovo A, Bocchini F, Shafiq Y, Trentin M, Paschetto M, et al.
Confl Health
. 2024 Apr;
18(1):34.
PMID: 38649938
Background: The Taliban takeover in August 2021 ended a decades-long conflict in Afghanistan. Yet, along with improved security, there have been collateral changes, such as the exacerbation of the economic...
4.
Miccio R, Quattrociocchi M, Valgoi L, Chatenoud L, Lentini S, Giovanella E, et al.
Front Pediatr
. 2021 Sep;
9:704729.
PMID: 34490162
Rheumatic heart disease is endemic in Sub-Saharan Africa and while efforts are under way to boost prophylaxis and early diagnosis, access to cardiac surgery is rarely affordable. In this article,...
5.
Colavita F, Biava M, Castilletti C, Lanini S, Miccio R, Portella G, et al.
Viruses
. 2019 Apr;
11(4).
PMID: 31018522
Ebola virus (EBOV) infection is characterized by an excessive inflammatory response, a loss of lymphocytes and a general paralysis of the immune system, however pathophysiological mechanisms are not fully understood....
6.
Langer M, Portella G, Finazzi S, Chatenoud L, Lanini S, Vairo F, et al.
Intensive Care Med
. 2018 Aug;
44(8):1266-1275.
PMID: 30062576
Purpose: We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC)...
7.
Lanini S, Portella G, Vairo F, Kobinger G, Pesenti A, Langer M, et al.
Clin Infect Dis
. 2017 Oct;
66(1):36-44.
PMID: 29020340
Background: Pathogenesis of Ebola virus disease remains poorly understood. We used concomitant determination of routine laboratory biomarkers and Ebola viremia to explore the potential role of viral replication in specific...
8.
Colavita F, Biava M, Castilletti C, Quartu S, Vairo F, Caglioti C, et al.
Emerg Infect Dis
. 2017 May;
23(6):1035-1037.
PMID: 28518027
The recent Ebola outbreak in West Africa caused breakdowns in public health systems, which might have caused outbreaks of vaccine-preventable diseases. We tested 80 patients admitted to an Ebola treatment...
9.
Lanini S, Portella G, Vairo F, Kobinger G, Pesenti A, Langer M, et al.
J Clin Invest
. 2015 Nov;
125(12):4692-8.
PMID: 26551684
Background: Infection with Ebola virus (EBOV) results in a life-threatening disease, with reported mortality rates between 50%-70%. The factors that determine patient survival are poorly understood; however, clinical observations indicate...
10.
Capobianchi M, Gruber C, Carletti F, Meschi S, Castilletti C, Vairo F, et al.
Genome Announc
. 2015 Sep;
3(5).
PMID: 26404609
We report the complete genome sequence of Ebola virus from a health worker linked to a cluster of cases occurring in the fishing community of Aberdeen, Sierra Leone (February 2015),...